GCP
ETNB

GSA Capital Partners’s 89bio ETNB Stock Holding History

GSA Capital Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,455
Closed -$221K – 1776
2025
Q2 		$221K Buy
+22,455
New +$186K 0.02% 1454
2023
Q4 		– Sell
-22,050
Closed -$340K – 1615
2023
Q3 		$340K Buy
+22,050
New +$370K 0.03% 1009
2023
Q2 		– Sell
-15,056
Closed -$229K – 1619
2023
Q1 		$229K Sell
15,056
-32,597
-68% -$425K 0.02% 1186
2022
Q4 		$607K Buy
+47,653
New +$429K 0.08% 482
2022
Q2 		– Sell
-92,815
Closed -$350K – 1501
2022
Q1 		$350K Buy
92,815
+47,619
+105% +$307K 0.05% 783
2021
Q4 		$591K Buy
45,196
+17,665
+64% +$279K 0.07% 496
2021
Q3 		$539K Buy
+27,531
New +$503K 0.05% 657
2021
Q2 		– Sell
-17,761
Closed -$421K – 1382
2021
Q1 		$421K Buy
17,761
+5,987
+51% +$138K 0.07% 438
2020
Q4 		$287K Buy
+11,774
New +$301K 0.05% 761

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GSA Capital Partners's ETNB Position: Q3 2025 in Review

GSA Capital Partners sold out of 89bio (ETNB) in Q3 2025, closing a stake of 22,455 shares — an estimated $221K sold.

GSA Capital Partners first reported a position in ETNB in Q4 2020 and held it in 9 quarters. The position peaked at $607K in Q4 2022. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • GSA Capital Partners reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • GSA Capital Partners sold 22,455 89bio shares in Q3 2025, an estimated $221K.
  • GSA Capital Partners first reported a position in 89bio in Q4 2020 and held it in 9 quarters.
  • GSA Capital Partners's 89bio position peaked at $607K in Q4 2022.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.